Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Alan Fournier, Pennant Capital Boost Stake in BioScrip

Alan Fournier‘s hedge fund, Pennant Capital Management, reported in a new filing boosting its exposure at BioScrip Inc (NASDAQ:BIOS) to some 5.74 million shares, from 1.64 million disclosed in its latest 13F. The stake is passive by nature and amasses 8.44% of BioScrip’s common stock.


Disclosure: none

Recommended Reading:

Ariel Investments Reports More Moves Into Dover Motorsports, Edgewater Technology & Others

Cannell Discloses Holding 5.54M Shares of ValueVision

John Rogers, Ariel Also Disclose a 10.9% Stake in Cumberland Pharmaceuticals